Form 4: Jaguar Health CFO Carol R. Lizak Reports Stock Transactions
SEC Form 4 Filing
Carol R. Lizak, CFO of Jaguar Health, Inc., reports the vesting and conversion of restricted stock units into common stock.
Summary
- On May 17, 2024, Carol R. Lizak, the Chief Financial Officer of Jaguar Health, Inc., reported transactions involving the company's stock.
- Lizak converted 431 restricted stock units into common stock.
- Following the transaction, Lizak directly owns 1,042 shares of common stock and indirectly owns 106 shares through the Peter & Carol Lizak Revocable Trust.
- The restricted stock units were originally approved on March 28, 2022, and vest in three equal annual installments starting May 17, 2023.
Sentiment
Score: 5
Explanation: This is a routine filing indicating standard executive compensation practices; neither particularly positive nor negative.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common for publicly traded companies.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| March 28, 2022 | Restricted stock units originally approved by the issuer's board of directors. |
| January 23, 2023 | Jaguar Health effected a 75-for-1 reverse stock split. |
| May 17, 2023 | Restricted stock units vest in three equal annual installments beginning on this date. |
| May 17, 2024 | Carol R. Lizak converted 431 restricted stock units into common stock. |
| May 21, 2024 | Date of signature for the Form 4 filing. |
Keywords
Jaguar Health, JAGX, Carol R. Lizak, Form 4, Stock Transaction, Restricted Stock Units, Beneficial Ownership, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.